Cilostazol drug study
Web• Designed study protocols and executed in vivo and in vitro studies. • Provided study reports for both internal and regulatory filing (cilostazol (Pletal®), tetomilast, and tolvaptan (Samsca WebSep 21, 2024 · Cilostazol is a quinolone derivative primarily used to treat intermittent claudication due to peripheral vascular disease, the FDA-approved indication. …
Cilostazol drug study
Did you know?
WebJun 1, 2009 · Cilostazol could potentiate the effects of nitric oxide donors such as sildenafil and should be used with caution in patients taking these drugs. Cilostazol helps with the symptoms of intermittent claudication, however the overall gains were modest and show little advantage over supervised exercise programs. 3 Cilostazol should not be used in ... WebApr 1, 2024 · Cilostazol may induce tachycardia, palpitation, tachyarrhythmia or hypotension. The increase in heart rate associated with Cilostazol is approximately 5 to 7 bpm. Patients with a history of ischemic heart disease may be at risk for exacerbations of angina pectoris or myocardial infarction.
WebNov 1, 2024 · Cilostazol opens blood vessels and reduces the formation of blood clots. The standard treatment of these hemorrhages currently involves the use of nimodipine which also relaxes blood vessels and allows blood to flow more freely. The combination of these two drugs cilostazol and nimodipine may improve neurologic outcomes after surgery. … WebFeb 22, 2024 · Cilostazol is a phosphodiesterase 3 inhibitor with antiplatelet, antithrombotic, and vasodilatory properties, whose efficacy and safety has been investigated in patients with ischemic stroke. 4, 5, 6 Phosphodiesterase inhibitors, compared with other antiplatelet agents, have 2 potentially advantageous properties for moyamoya disease: (1) less …
WebCilostazol comes as a tablet to take by mouth. It is usually taken twice a day, at least 30 minutes before or 2 hours after breakfast and dinner. Take cilostazol at around the same times every day. Follow the directions on the prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. WebJan 1, 2000 · The purpose of this study was to compare the relative efficacy and safety of the cilostazol, a phosphodiesterace inhibitor, and pentyoxifylline for calf claudication. ... Cilostazol (Pletal™) is the first drug to demonstrate a clear benefit for intermittent claudication. It is a modest vasodilator, inhibits platelet aggregation, and has a ...
WebCilostazol and Diabetes - a phase IV clinical study of FDA data Summary: Diabetes is found among people who take Cilostazol, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months. The phase IV clinical study analyzes which people take Cilostazol and have Diabetes.
WebThis long-term study demonstrated no safety signal for cilostazol on all-cause or cardiovascular mortality. The study, however, was underpowered to detect a small … sql get current time without dateWebJul 10, 2024 · Cilostazol for Secondary Prevention of Stroke and Cognitive Decline Stroke Background and Purpose: Cilostazol, a … sql get end of month dateWebCilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction Authors F Gotoh 1 , H Tohgi , S Hirai , A Terashi , Y Fukuuchi , E Otomo , Y Shinohara , E Itoh , T Matsuda , T Sawada , T Yamaguchi , K Nishimaru , Y Ohashi Affiliation sheriff way watfordWebThe phase IV clinical study analyzes what interactions people who take Cilostazol and Lexiscan have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly. Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. sql get distinct by columnWebCilostazol is an antiplatelet agent with vasodilating effects that functions by increasing the intracellular concentration of cyclic adenosine monophosphate. We have previously … sql get hours and minutes between two datesWebMay 7, 2013 · The STOP-IC study is the first large prospective trial investigating the effect of the combination of cilostazol 100 mg twice daily with aspirin 100 mg optimal immunomodulating dose versus aspirin 100 mg optimal immunomodulating dose only. 1 Patients with a meaningful mean lesion length of almost 13 cm were suitable for … sql get last 2 characters from a stringWebSep 11, 2010 · The antiplatelet drug cilostazol is efficacious for prevention of stroke recurrence compared with placebo. We designed the second Cilostazol Stroke Prevention Study (CSPS 2) to establish non-inferiority of cilostazol versus aspirin for prevention of stroke, and to compare the efficacy and safety of cilostazol and aspirin in patients with … sheriff water patrol